Delivery Order SPE2DB22D2206-SPE2DB25FGC85

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Indocyanine Green 25 mg vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $6,426.91 and an ultimate completion date of July 24, 2024. This is a delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,389.30, is a Firm Fixed Price Delivery Order for the supply of 4566660777 - Indocyanine Green 25 mg Vials. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,222.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,634,202 units of Indocyanine Green 25 mg vials and has a completion date of December 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,414.22 firm fixed-price delivery order is for the supply of 4567435454 Indocyanine Green 25 mg vials. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,445.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Indocyanine Green 25 mg vials, a specialized medical product used in various medical procedures. The contract is a Firm Fixed Price Delivery Order that will run through December 9, 2024. Additionally, AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,222.50 firm fixed-price delivery order covers the supply of 4566682363 - Indocyanine Green 25 mg vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valid through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,743.22 firm fixed-price delivery order is for the supply of 4,568,252,838 units of Indocyanine Green 25 mg vials, with a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,667.50 for the supply of Indocyanine Green 25 mg vials. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 2024. The contract is a firm fixed-price arrangement and does not have a specific set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.00 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FDPP3) is for the supply of Indocyanine Green 25 mg vials, with a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,902.06 firm fixed price delivery order is for the supply of 25 mg vials of Indocyanine Green, a medical dye used in various healthcare procedures. The contract has a period of performance through May 8, 2024 and was not designated as a set-aside award. Amerisourcebergen holds a larger $999,999,999 Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGC85
    Delivery Order

This federal contract award is for the delivery of Indocyanine Green 25 mg vials to the Defense Logistics Agency (DLA). The $1,222.50 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:54 AM